ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Mereo BioPharma Group PLC

Mereo BioPharma Group PLC (MREO)

3.72
0.04
(1.09%)
終了 11月24日 6:00AM
3.72
-0.005
(-0.13%)
取引時間後: 9:42AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
3.72
買値
3.61
売値
3.72
出来高
831,486
3.645 日の範囲 3.81
1.86 52 週間の範囲 5.02
時価総額
前日終値
3.68
始値
3.70
最終取引時間
財務取引量
US$ 3,100,708
VWAP
3.7291
平均取引量 (3 か月)
747,073
発行済株式数
485,070,000
配当利回り
-
PER
-54.39
1 株当たり利益 (EPS)
-0.07
歳入
8.04M
純利益
-33.18M

Mereo BioPharma Group PLC について

Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with ad... Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with advanced solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
London, Gbr
設立
-
Mereo BioPharma Group PLC is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker MREO. The last closing price for Mereo BioPharma was US$3.68. Over the last year, Mereo BioPharma shares have traded in a share price range of US$ 1.86 to US$ 5.02.

Mereo BioPharma currently has 485,070,000 shares in issue. The market capitalisation of Mereo BioPharma is US$1.79 billion. Mereo BioPharma has a price to earnings ratio (PE ratio) of -54.39.

MREO 最新ニュース

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Setrusumab receives Breakthrough Therapy designation from the FDA Cash of $80.5 million as of September 30, 2024, expected to fund operations into 2027 LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE...

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.07-1.846965699213.793.823.17513261133.49014801CS
4-0.61-14.08775981524.334.423.1757958713.84391882CS
12-0.88-19.13043478264.64.79993.1757470734.13170701CS
260.6922.77227722773.035.022.8759529914.00481252CS
521.4161.0389610392.315.021.8611225953.5302609CS
1561.7185.07462686572.015.020.30114200581.86051659CS
2601.1745.88235294122.555.020.30112545122.30716386CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M

MREO Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock